Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings

A Bingham, JK Drake… - Archives of pediatrics & …, 2009 - jamanetwork.com
… for HPV vaccine introduction in developing country settings … or willingness to support vaccine
delivery at multiple levels, 9 and … beginning of the planning process for vaccine introduction. …

Emerging human papillomavirus vaccines

B Ma, B Maraj, NP Tran, J Knoff, A Chen… - Expert opinion on …, 2012 - Taylor & Francis
… In high-resource countries, the implementation of organized gynecological screening …
preventive HPV vaccines may further impact the cervical cancer rates in developed countries. …

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …

KT Simms, J Steinberg, M Caruana, MA Smith… - The lancet …, 2019 - thelancet.com
… Although more than 30% of females aged 10–20 years in developed countriesDevelopment
Index (HDI) country with early and high coverage implementation of both HPV vaccination

Human papillomavirus vaccines

J Schiller, D Lowy, L Markowithz - Vaccines. 6th ed. Philadelphia …, 2012 - books.google.com
… has been increasing in many developed countries. 8, 13 Human papillomavirus vaccination
should also have the potential to reduce the incidence of these HPV-associated cancers. …

Introduction of human papillomavirus vaccination in Nordic countries

BB Sander, M Rebolj, P Valentiner-Branth, E Lynge - Vaccine, 2012 - Elsevier
developing countries. Only 50 years ago the burden of cervical cancer was high also in
developed countries … Persistent infection with oncogenic types of Human Papillomavirus (HPV) is …

Human papillomavirus vaccines: an updated review

L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
… Population-level impact and herd effects following the introduction of human papillomavirus
vaccination programmes: Updated systematic review and meta-analysis. Lancet 2019, 394, …

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

M Jit, N Demarteau, E Elbasha, G Ginsberg, J Kim… - BMC medicine, 2011 - Springer
… economic appraisals of vaccines. To provide information about the feasibility of using such
models in a developing country setting, we evaluated models of HPV vaccination in terms of …

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review

M Fesenfeld, R Hutubessy, M Jit - Vaccine, 2013 - Elsevier
… that human papillomavirus vaccination is cost-effective before vaccine introduction. We …
evaluations of human papillomavirus vaccination in low and middle income countries. We …

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination

ME Fernández, JD Allen, R Mistry… - Annual review of public …, 2010 - annualreviews.org
… Finally, research is needed in developing countries and among groups at highest risk for
HPV-associated disease. Women who are not typically screened for cervical cancer are also …

Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa

R Sankaranarayanan, R Anorlu, G Sangwa-Lugoma… - Vaccine, 2013 - Elsevier
development that is likely to improve the prospects of HPV vaccination availability to girls in
less developed countries… inclusion of HPV vaccine in the portfolio of new vaccines offered by …